SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-004217
Filing Date
2019-05-07
Accepted
2019-05-07 15:18:11
Documents
77
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q clvs-20190331x10q.htm 10-Q 1904349
2 EX-31.1 clvs-20190331ex311051fdc.htm EX-31.1 19884
3 EX-31.2 clvs-20190331ex312ed7b07.htm EX-31.2 20122
4 EX-32.1 clvs-20190331ex321f1e71a.htm EX-32.1 7993
5 EX-32.2 clvs-20190331ex32224e9a8.htm EX-32.2 8377
  Complete submission text file 0001558370-19-004217.txt   7453963

Data Files

Seq Description Document Type Size
6 EX-101.INS clvs-20190331.xml EX-101.INS 1580721
7 EX-101.SCH clvs-20190331.xsd EX-101.SCH 57981
8 EX-101.CAL clvs-20190331_cal.xml EX-101.CAL 78919
9 EX-101.DEF clvs-20190331_def.xml EX-101.DEF 155768
10 EX-101.LAB clvs-20190331_lab.xml EX-101.LAB 557153
11 EX-101.PRE clvs-20190331_pre.xml EX-101.PRE 361220
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 19802764
SIC: 2834 Pharmaceutical Preparations